Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Proposed dividend for Krka shareholders.pdfProposed dividend for Krka shareholders

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 17 / 2024
Date of issue: 2024-04-04
Short name of the issuer
KRKA
Subject
Proposed dividend for Krka shareholders 13.6% higher than last year
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
Based on Article 26 of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto informs the public on the proposed allocation of the 2023 accumulated profit.

The document is attached.


The notice will be published on the Company's website (www.krka.biz) from 4 April 2024 onwards, for a period of at least 5 years.
Annexes
File Description
Proposed dividend for Krka shareholders.pdf
Proposed dividend for Krka shareholders.pdf		 Proposed dividend for Krka shareholders

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-04-04 Jože Colarič President of the Management Board and CEO
20240404_081640_0993746009_Proposed_dividend_for_Krka_shareholders.pdf

Pobierz